Viewing Study NCT05612035


Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2025-12-25 @ 8:05 PM
Study NCT ID: NCT05612035
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-07
First Post: 2022-11-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-03-16
Start Date Type: ACTUAL
Primary Completion Date: 2026-04-07
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-10-07
Completion Date Type: ESTIMATED
First Submit Date: 2022-11-03
First Submit QC Date: None
Study First Post Date: 2022-11-10
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-10-03
Last Update Post Date: 2025-10-07
Last Update Post Date Type: ESTIMATED